Trials
Coronavirus: Concern grows over potential superspreader event during US Capitol riot
Concerns are mounting about the health of lawmakers and other people in the Capitol last week, after the first member to test positive for the Coronavirus (COVID-19) since Wednesday’s chaos, said she believed she was exposed in a crowded hiding place with hundreds of other legislators. Rep. Bonnie Watson Coleman, D-N.J., tested positive on Monday while experiencing mild symptoms, and said in a statement that she believes she caught the virus from her fellow lawmakers while hunkering down as Capitol Police struggled for hours to contain a Trump-inspired mob attack on the Capitol. Lawmakers were trapped in a room near the Capitol with hundreds of others, in some cases for hours, where at least one person who later tested positive for the coronavirus was present. The Office of the Attending P...
Coronavirus: Prof. Maurice Iwu restates efficacy of herbal medicine
Bioresources Development Group (BDG) chairman, Prof. Maurice Iwu has restated the efficacy of herbal medicine in the treatment of the COVID-19 cases as the virus enters variant stage globally. The former chairman of Independent National Electoral Commission (INEC) and eminent Professor of Pharmacognosy, Iwu, in a chat with Vanguard said that the effectiveness of special herbal drugs produced in the country, stands the chance of combating the disease at an early stage, but noted that the slow pace in acceptance and approval hinders its feasibility. Iwu also pointed that herbal extracts from a plant, “Andrographis Paniculata”, commonly known as green chiretta, already approved by the Food and Drug Administration (FDA) of Thailand is on its way to serve as an alternative treatment to the seve...
Russian coronavirus vaccine trials begin in UAE as cases rise
Abu Dhabi has started Phase III clinical trials of Russia’s experimental COVID-19 vaccine, known as Sputnik V, amid a surge in infections in the United Arab Emirates, Abu Dhabi’s media office said on Thursday. The human trial, announced in October before the recent rise in cases, is initially seeking up to 500 volunteers to be vaccinated at a hospital in the emirate of Abu Dhabi. Two doses of the vaccine will be given, 20 days apart, to volunteers, the statement said. Participants will have to be 18 years or older, have not previously been infected with COVID-19 or participated in other COVID-19 vaccine trials, it said. The UAE is also conducting Phase III trials of a COVID-19 vaccine developed by China National Pharmaceutical Group (Sinopharm). The UAE has approved the vaccine and it is a...
ABC: California nurse tests positive over a week after receiving Pfizer coronavirus vaccine
A 45-year-old nurse in California tested positive for COVID-19 more than a week after receiving Pfizer Inc’s coronavirus vaccine, an ABC News affiliate reported on Tuesday. Matthew W., a nurse at two different local hospitals, said in a Facebook post on December 18 that he had received the Pfizer vaccine, telling the ABC News affiliate that his arm was sore for a day but that he had suffered no other side-effects. Six days later on Christmas Eve, he became sick after working a shift in the COVID-19 unit, the report added. He got the chills and later came down with muscle aches and fatigue. He went to a drive-up hospital testing site and tested positive for COVID-19 the day after Christmas, the report said. Christian Ramers, an infectious disease specialist with Family Health Centers of San...
Moderna, McKesson, U.S. Army general begin rolling out new coronavirus vaccine
Distribution of Moderna Inc’s COVID-19 vaccine to more than 3,700 locations in the United States has begun, vastly widening the rollout started last week by Pfizer Inc, U.S Army General Gustave Perna said on Saturday. Moderna has already moved vaccines from its manufacturing plants to warehouses operated by distributor McKesson Corp where they are being packed into containers and loaded on to trucks on Saturday, Perna said during a news conference. Trucks will set out on Sunday and shipments will start reaching healthcare providers as soon as Monday, he said. The Food and Drug Administration on Friday approved an emergency use authorization for Moderna’s vaccine, the second COVID-19 vaccine to be approved. The jab developed by Pfizer and its German partner BioNTech SE was approved Dec. 11....
First Americans vaccinated as U.S. death toll passes 300,000
An intensive care unit nurse became the first person in the United States to receive the Pfizer/BioNTech COVID-19 vaccine on Monday, calling it a sign that “healing is coming,” as the U.S. coronavirus death toll crossed a staggering 300,000 lives lost. Sandra Lindsay, who has treated some of the sickest COVID-19 patients for months, was given the vaccine at Long Island Jewish Medical Center in the New York City borough of Queens, an early epicenter of the country’s COVID-19 outbreak, receiving applause on a livestream with New York Governor Andrew Cuomo. “It didn’t feel any different from taking any other vaccine,” Lindsay said. “I feel hopeful today, relieved. I feel like healing is coming. I hope this marks the beginning of the end of a very painful time in our history. “I want to instil...
FDA: Independent committee recommends authorization of coronavirus vaccine
An independent committee of experts recommended Thursday that the Food and Drug Administration authorize the Pfizer and BioNTech COVID-19 vaccine for people over the age of 16. Now, the FDA will decide whether to follow that recommendation. The agency could announce a decision within days. If they do authorize the vaccine, health care workers could begin receiving the shots almost immediately. The Vaccines and Related Biological Products Advisory Committee (VRBPAC) met all day to review data on the vaccine, discuss plans for distribution, and outline plans for continued research. FDA scientists published a report about the vaccine on Tuesday, which analyzed data from the pharmaceutical companies and found that the vaccine was safe and 95 percent at preventing symptomatic COVID-19. Data fro...
India’s Serum Institute seeks approval for COVID-19 vaccine
The Serum Institute of India, the world’s largest vaccine producer by volume, has sought government approval for emergency-use authorisation of the coronavirus vaccine that it has developed in partnership with the University of Oxford and British drugmaker AstraZeneca. “As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorisation for the first made-in-India vaccine, COVISHIELD,” the company CEO Adar Poonawalla tweeted on Monday. The experimental vaccine can be stored at two to eight degrees Celsius and can be distributed more easily in India, which has the world’s second-highest number of infections at 9.6 million. The company has applied to the Drugs Controller General of India (DCGI), with Poonawalla saying the vaccine will “save countless lives” witho...
France: Coronavirus vaccine will be free for all
France will ensure free COVID-19 vaccinations for all who are in its social security system and has earmarked 1.5 billion euros of next year’s social security budget to cover the cost, Prime Minister Jean Castex said on Thursday. Castex said the vaccination campaign would begin in a matter of weeks, pending regulatory approval by the European Medicines Agency. The inoculation programme would be staggered over three categories of people, he said, commencing with the most vulnerable in nursing homes. “The vaccination will be free for all,” Castex told a press conference. France has ordered some 200 million doses from different pharmaceutical companies developing vaccines, Castex said, enough to inoculate 100 million people – more than France’s population. The COVID-19 vaccination will be vol...
Interpol raises the alarm over fake coronavirus vaccines
The International Criminal Police Organisation (INTERPOL) has alerted Nigeria, South Africa, the United Kingdom, the United States, and 190 other countries of threat from organised criminal groups during the upcoming COVID-19 vaccination campaigns, including fake vaccines and the theft of supplies. The alert came as the UK yesterday became the first country in the world to approve the Pfizer/BioNTech coronavirus vaccine for widespread use. The need for a vaccine has become more urgent globally and nationally with Nigeria recording over 67,000 COVID-19 infections and over 1,000 associated fatalities, according to the Nigeria Centre for Disease Control. The World Health Organisation (WHO) has so far identified 49 “candidate vaccines” at the stage of clinical trials in humans. Hopes are high ...
EU criticises ‘hasty’ UK approval of coronavirus vaccine
The European Union criticised Britain’s rapid approval of Pfizer and BioNTech’s COVID-19 vaccine on Wednesday, saying its own procedure was more thorough, after Britain became the first western country to endorse a COVID-19 shot. The move to grant emergency authorisation to the Pfizer/BioNTech vaccine has been seen by many as a political coup for UK Prime Minister Boris Johnson, who has led his country out of the EU and faced criticism for his handling of the pandemic. The decision was made under an ultra-fast, emergency approval process, which allowed the British drugs regulator to temporarily authorise the vaccine only ten days after it began examining data from large-scale trials. In an unusually blunt statement, the European Medicines Agency (EMA), which is in charge of approving COVID...
Coronavirus vaccine breakthrough raises hopes of rapid global rollout
A coronavirus vaccine developed by Britain’s University of Oxford and the pharmaceutical firm AstraZeneca has shown successful results in early trials. If it is approved by regulators, the vaccine appears suitable for a fast rollout around the globe. Early analysis of trials involving 20,000 volunteers in Britain and Brazil show the vaccine is at least 62% effective after two doses. In volunteers given a different dosing regimen — a half dose, followed by a full dose — that figure rose to 90%. The average efficacy of the two dosing methods is 70%. None of those given the vaccine developed severe COVID-19 illness. Andrew Pollard, director of the Oxford Vaccine Group, said the recent successful trials of three different vaccines by Oxford-AstraZeneca, Pfizer-BioNTech and Moderna, represent a...
